Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mefenamic acid 250mg/5ml oral suspension
1001010N0AAAGAG
|
Mefenamic acid | Mefenamic acid | Musculoskeletal and Joint Diseases | No data available |
|
Mefenamic acid 500mg/5ml oral suspension
1001010N0AAAHAH
|
Mefenamic acid | Mefenamic acid | Musculoskeletal and Joint Diseases | No data available |
|
Meloxicam 15mg suppositories
1001010AAAAACAC
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | No data available |
|
Meloxicam 15mg/5ml oral suspension
1001010AAAAAIAI
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | No data available |
|
Meloxicam 3.75mg/5ml oral suspension
1001010AAAAAGAG
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | No data available |
|
Meloxicam 7.5mg suppositories
1001010AAAAADAD
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | No data available |
|
Meloxicam 7.5mg/5ml oral suspension
1001010AAAAAHAH
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | No data available |
|
Mestinon 60mg/5ml syrup
1002010Q0BBAEBF
|
Mestinon | Pyridostigmine bromide | Musculoskeletal and Joint Diseases | No data available |
|
Metalcaptase gastro-resistant 150mg tablets
1001030F0BDAAAM
|
Metalcaptase | Penicillamine | Musculoskeletal and Joint Diseases | No data available |
|
Metalcaptase gastro-resistant 300mg tablets
1001030F0BDABAN
|
Metalcaptase | Penicillamine | Musculoskeletal and Joint Diseases | No data available |
|
Methocarbamol 375mg/5ml oral suspension
1002020S0AAACAC
|
Methocarbamol | Methocarbamol | Musculoskeletal and Joint Diseases | No data available |
|
Methofill 27.5mg/0.55ml inj pre-filled injector
1001030U0BGAIBZ
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methofill 27.5mg/0.55ml inj pre-filled syringes
1001030U0BGASBN
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 10mg/1ml inj pre-filled syringes
1001030U0AABBBB
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 12mg/5ml oral liquid
1001030U0AAASAS
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 15mg/1.5ml inj pre-filled syringes
1001030U0AABCBC
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 15mg/5ml oral liquid
1001030U0AAARAR
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 17.5mg/5ml oral liquid
1001030U0AAATAT
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 18mg/5ml oral liquid
1001030U0AAAXAX
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 1mg/5ml oral liquid
1001030U0AAALAL
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 20mg/1ml inj pre-filled syringes
1001030U0AABSBS
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 20mg/5ml oral liquid
1001030U0AAAVAV
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 22.5mg/5ml oral liquid
1001030U0AAAYAY
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 25mg/1.25ml inj pre-filled syringes
1001030U0AABPBP
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 25mg/2.5ml inj pre-filled syringes
1001030U0AABDBD
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.